Anna I. Hooijkaas - Concepedia

Author

Anna I. Hooijkaas

Also Known As

Anna Hooijkaas, Anna I Hooijkaas, Anna I. Hooijkaas

Publications

863

Citations

H-Index

Concepts

All Affiliations

Anna I. Hooijkaas is an author at The Netherlands Cancer Institute specializing in medicine, immunotherapy, and tumor biology.

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	821
2	Immunology	4	4	743
3	Cell Biology	3	3	574
4	Cellular Therapies	1	1	431
5	Pathology	1	1	14

Anna I. Hooijkaas

Publications

821

Citations

H-Index

Page 1

	Year	Citations
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy Gavin Bendle, Carsten Linnemann, Anna I. Hooijkaas, Nature Medicine Gene TherapiesCell TherapyTransplantationAutoimmune DiseaseT-regulatory Cell	2010	431
Overall survival and PD‐L1 expression in metastasized malignant melanoma Jules Gadiot, Anna I. Hooijkaas, Andrew Kaiser, Cancer ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyCancer Biology	2010	220
Selective BRAF inhibition decreases tumor-resident lymphocyte frequencies in a mouse model of human melanoma Anna I. Hooijkaas, Jules Gadiot, Michelle Morrow, OncoImmunology ImmunologyImmunoeditingImmune SystemImmunotherapyTumor Biology	2012	79
Targeting BRAF in an Inducible Murine Model of Melanoma Anna I. Hooijkaas, Jules Gadiot, Martin van der Valk, American Journal Of Pathology PhotocarcinogenesisMelanomaMedicineCell BiologyInducible Murine Model	2012	64
Expression of the embryological morphogen Nodal in stage III/IV melanoma Anna I. Hooijkaas, Jules Gadiot, Hester van Boven, Melanoma Research Cancer ImmunosurveillanceDevelopmental BiologyEmbryological Morphogen NodalMedicineMelanoma	2011	14
Synchronous BRAFV600E and MEK inhibition leads to superior control of murine melanoma by limiting MEK inhibitor induced skin toxicity Christian Blank, Jules Gadiot, Anna I. Hooijkaas, OncoTargets and Therapy ImmunologyDermatologyImmunotherapyTumor BiologyReceptor Tyrosine Kinase	2013	13

Page 1